Pharmalot -- Henry Waxman continues to have his suspicions about the FDA. In a letter today to FDA Commish Andy von Eschenbach (pictured to the left) after receiving internal FDA e-mails about agency decisions over the couple of years. His conclusion? “Political appointees at the agency may be promoting industry priorities at the expense of FDA’s core public health mission,” according to Waxman.
